⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 23, 2024Open Access

Massively parallel reporter assays and mouse transgenic assays provide complementary information about neuronal enhancer activity

Michael Kosicki Dianne Laboy Cintrón Nicholas F. Page Ilias Georgakopoulos‐Soares Jennifer A. Akiyama Ingrid Plajzer-Frick Catherine S. Novak Momoe Kato Riana D. Hunter Kianna von Maydell Sarah Barton Patrick Godfrey Erik Beckman Stephan Sanders L Pennacchio Nadav Ahituv

View Full Paper

Ask AI

Bookmark

Share

Abstract

Genetic studies find hundreds of thousands of noncoding variants associated with psychiatric disorders. Massively parallel reporter assays (MPRAs) and

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kosicki et al. (2024) studied this question.

synapsesocial.com/papers/68e6de7cb6db64358765a7c3 https://doi.org/10.1101/2024.04.22.590634

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1USING MASSIVELY PARALLEL REPORTER ASSAYS TO INVESTIGATE THE NON-CODING GENETICS OF BRAIN DISORDERSOriginal Research · 2026
2Characterization of enhancer activity in early human neurodevelopment using Massively Parallel Reporter Assay (MPRA) and forebrain organoids2024 · 21 citations
3In silico generation and augmentation of regulatory variants from massively parallel reporter assay using conditional variational autoencoder2024
4Massively parallel reporter assay for mapping gene-specific regulatory regions at single-nucleotide resolutionOriginal Research · 2026
5Massively parallel reporter assay for mapping gene-specific regulatory regions at single nucleotide resolution2025